Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Liabilities (2020 - 2025)

Core Scientific's Total Liabilities history spans 6 years, with the latest figure at $3.3 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 36.85% year-over-year to $3.3 billion; the TTM value through Dec 2025 reached $3.3 billion, up 36.85%, while the annual FY2025 figure was $3.3 billion, 36.85% up from the prior year.
  • Total Liabilities for Q4 2025 was $3.3 billion at Core Scientific, down from $3.4 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $3.4 billion in Q3 2025 and bottomed at $29.8 million in Q1 2021.
  • The 5-year median for Total Liabilities is $1.3 billion (2022), against an average of $1.5 billion.
  • The largest annual shift saw Total Liabilities surged 263294400.0% in 2021 before it decreased 26.62% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $1.1 billion in 2021, then grew by 15.56% to $1.2 billion in 2022, then rose by 7.56% to $1.3 billion in 2023, then skyrocketed by 84.78% to $2.4 billion in 2024, then soared by 36.85% to $3.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Total Liabilities are $3.3 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.0 billion (Q2 2025).